Discover your unique microbiome profile with advanced testing

Learn More →
Bacterium

Lactobacillus casei/paracasei

Common name: L. casei

Beneficial Digestive Gut Oral
Beneficial
Effect
Digestive
Impact
Gut, Oral
Location
Common
Prevalence
Last reviewed: December 27, 2024

Probiotic, immune modulation, metabolic health

Lactobacillus casei (including the closely related L. paracasei) is a highly researched probiotic species known for its versatile health benefits across gastrointestinal, metabolic, immune, and neurological systems. The most extensively studied strain is L. casei Shirota (LcS), discovered in 1930 and used in commercial fermented milk products worldwide[1].

Gastrointestinal Health Benefits

Scientifically accurate microscopy-style illustration of Lactobacillus casei/paracasei showing its characteristic gram-positive rod-shaped bacterium

Constipation Relief

Multiple randomized controlled trials demonstrate that L. casei strains improve constipation-related symptoms[2]:

  • Stool frequency: Increases bowel movements by 0.6-1.5 times per week
  • Stool consistency: Improves Bristol Stool Scale scores toward normal
  • Colonic transit: Enhances gut motility through organic acid production (acetate, lactate)
  • Mechanism: Fermentation produces short-chain fatty acids that stimulate colonic muscle contractions and water secretion

Diarrhea Prevention and Treatment

L. casei is effective against various forms of diarrhea[3]:

  • Acute diarrhea: Reduces duration by approximately 24 hours in children
  • Antibiotic-associated diarrhea (AAD): Prevents AAD when co-administered with antibiotics
  • Rotavirus gastroenteritis: Particularly effective in pediatric rotavirus infections
  • Traveler's diarrhea: Protective effects when consumed before and during travel

Inflammatory Bowel Disease

L. casei DG and other strains demonstrate anti-inflammatory properties in IBD:

  • Reduces mucosal inflammatory cytokines (IL-1β, IL-6, TNF-α)
  • Enhances anti-inflammatory IL-10 production
  • Activates regulatory T cell responses
  • Suppresses pathogenic Th17 immunity
  • Mouse models show 60% reduction in colitis severity scores

Helicobacter pylori Eradication

Meta-analyses support L. casei as adjunctive therapy for H. pylori treatment:

  • Increases eradication rates by approximately 12%
  • Reduces antibiotic-associated side effects by 50%
  • Decreases gastrointestinal symptoms (nausea, diarrhea, bloating)
  • Enhances patient compliance with eradication regimens

Metabolic Health Benefits

Glycemic Control

Clinical trials in type 2 diabetes patients demonstrate metabolic improvements:

  • HbA1c reduction: 0.2-0.4% decrease over 12 weeks
  • Fasting glucose: Significant reductions in blood glucose levels
  • Insulin sensitivity: Improved HOMA-IR scores indicating reduced insulin resistance
  • Mechanisms: Enhanced GLP-1 secretion, improved gut barrier function, reduced systemic inflammation

Lipid Profile Improvements

L. casei supplementation affects cholesterol metabolism:

  • Decreases LDL cholesterol through bile salt hydrolase activity
  • Reduces total cholesterol levels
  • May improve HDL/LDL ratios
  • Bile acid deconjugation reduces cholesterol absorption

Weight Management

Studies in overweight individuals show:

  • Reductions in BMI and waist circumference
  • Decreased body fat percentage
  • Enhanced energy expenditure through SCFA production
  • Modulation of appetite-regulating hormones

Kidney Function Support

Emerging research shows benefits for chronic kidney disease:

  • Reduced serum creatinine and blood urea nitrogen
  • Decreased uremic toxins (p-cresol, indoxyl sulfate)
  • Improved estimated glomerular filtration rate (eGFR)
  • Enhanced gut barrier reducing bacterial translocation

Immunomodulatory Effects

Innate Immune Activation

L. casei stimulates multiple arms of innate immunity:

  • Dendritic cell maturation: Activates via TLR2 and NOD2 receptor signaling
  • NK cell enhancement: Increases natural killer cell cytotoxicity against tumor cells
  • Cytokine modulation: Promotes IFN-γ and IL-12 supporting Th1 immunity
  • Macrophage activation: Enhances phagocytotic capacity

Adaptive Immune Modulation

Regulatory T cell induction is a key mechanism:

  • Induces CD4+CD25+FoxP3+ Tregs in gut-associated lymphoid tissue
  • Promotes oral tolerance to dietary antigens
  • Balances Th1/Th2/Th17 responses
  • Reduces autoimmune inflammatory responses

Gut-Brain Axis Effects

Stress and Anxiety Reduction

Double-blind trials demonstrate psychological benefits[4]:

  • Reduced perceived stress and anxiety scores during academic examinations
  • Improved mood under chronic stress conditions
  • Enhanced cognitive performance under pressure
  • Mechanisms include vagal nerve modulation and reduced cortisol

Cognitive Function

Preliminary research suggests cognitive benefits:

  • Improved attention and memory in stressed individuals
  • Potential applications in age-related cognitive decline
  • Gut microbiome-brain communication via neurotransmitter precursors

Mechanisms of Action

Gut Barrier Enhancement

  • Strengthens tight junctions between epithelial cells
  • Increases mucin production protecting the mucosal surface
  • Reduces intestinal permeability ("leaky gut")
  • Prevents bacterial translocation to systemic circulation

Antimicrobial Activity

  • Produces bacteriocins and organic acids inhibiting pathogens
  • Competes for adhesion sites on intestinal epithelium
  • Enhances antimicrobial peptide production (defensins)
  • Modulates quorum sensing in pathogenic bacteria

SCFA Production

  • Ferments dietary fibers to acetate, propionate, and butyrate
  • SCFAs serve as energy source for colonocytes
  • Stimulate GLP-1 and PYY hormone secretion
  • Regulate immune cell function and inflammation

Safety Profile

L. casei has an excellent safety record with over 80 years of documented use in fermented foods. It is recognized as GRAS (Generally Recognized as Safe) by the FDA and approved for use in infants, children, adults, and elderly populations. Side effects are rare and typically limited to mild gastrointestinal symptoms during initial use.

Dietary Sources and Supplementation

Natural Sources

  • Fermented milk products (Yakult, some yogurts)
  • Traditional cheeses (Cheddar, Parmesan aging)
  • Fermented vegetables
  • Some sourdough breads

Supplementation

  • Available as single-strain or multi-strain probiotic formulations
  • Typical doses range from 1 billion to 10 billion CFU daily
  • Strain-specific benefits should guide product selection
  • Best consumed with meals to enhance survival through stomach acid

Documented Strains

Shirota

Lactobacillus casei Shirota

Extensive research
FERM BP-1366
Bowel regularity and constipation reliefAntibiotic-associated diarrhea preventionNK cell enhancement in healthy adultsUpper respiratory infection reduction

Key Findings

NK cell immune activity

NK cell activity significantly elevated in healthy and elderly adults

Bowel regularity

Significantly improved stool frequency and consistency in constipation

The most extensively studied L. casei strain with over 70 years of clinical research — the only L. casei strain with consistent evidence for enhancing NK cell cytotoxic activity in healthy adults and the elderly, representing a unique immunostimulatory profile not replicated by any other casei-group strain

DN-114 001

Lactobacillus casei DN-114 001

Moderate research
CNCM I-1518
Upper respiratory infection preventionAntibiotic-associated diarrhea preventionCommunity-acquired pneumonia risk reduction

Key Findings

Upper respiratory infections

Significantly reduced common cold duration and severity

The only L. casei strain demonstrated to reduce community-acquired pneumonia risk in elderly care-home residents in a large RCT, representing a uniquely documented respiratory outcome at the population level

DG

Lactobacillus casei DG

Moderate research
CNCM I-1572
Intestinal permeability restorationUlcerative colitis maintenancePost-antibiotic gut barrier repair

Key Findings

Intestinal permeability

Significantly reduced intestinal permeability biomarkers in IBD patients

Uniquely demonstrated to restore intestinal permeability markers (zonulin, alpha-1-antitrypsin) in patients with IBD and antibiotic-disrupted gut barrier — one of very few probiotic strains with direct clinical evidence for tight-junction restoration

KW3110

Lacticaseibacillus paracasei KW3110

Moderate research
FERM BP-08634
Seasonal allergic rhinitis (cedar pollinosis) reliefTh1 immune response enhancementTh2 cytokine suppression

Key Findings

Seasonal allergic rhinitis (hay fever)

Nasal symptoms, sneezing, and rhinorrhea significantly improved by week 4 vs placebo

Eosinophilic inflammation in allergy

Eosinophil cationic protein levels fell significantly alongside quality of life improvement

The only L. paracasei strain specifically selected from >100 candidates for maximal Th1-inducing (IL-12 ≥60% of standard) and Th2-suppressing (IL-4 <50% of standard) activity in vitro — confirmed in multiple Japanese cedar pollinosis RCTs with significant nasal symptom relief and eosinophil cationic protein reduction, and mechanistically shown to upregulate PD-L2 on dendritic cells driving Th2 inhibition in cervical lymph nodes

Associated Conditions

Related Organisms

Frequently Asked Questions

What is Lactobacillus casei/paracasei?

Lactobacillus casei/paracasei is a bacterium found in the human microbiome.

Where is Lactobacillus casei/paracasei found in the body?

Lactobacillus casei/paracasei is primarily found in the Gut, Oral.

What are the health impacts of Lactobacillus casei/paracasei?

Lactobacillus casei/paracasei primarily impacts Digestive and is beneficial for human health.

Research References

  1. Nagao F, Nakayama M, Muto T, et al.. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on immune function and the gut microbiota. Biosci Biotechnol Biochem. 2000. doi:10.1271/bbb.64.2706
  2. Koebnick C, Wagner I, Leitzmann P, et al.. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol. 2003. doi:10.1155/2003/654907
  3. Szajewska H, Kolodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhea in children and adults. Aliment Pharmacol Ther. 2015. doi:10.1111/apt.13404
  4. Takada M, Nishida K, Kataoka-Kato A, et al.. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms. Benef Microbes. 2016. doi:10.1111/nmo.12804